One OTC Statin Out, One More To Go

I was somewhat relieved to read an FDA advisory committee rejected Merck's request to grant over-the-counter (OTC) status to Mevachor late Friday afternoon. Folks, it didn't look good early on, as Mevachor sailed through early voting last Thursday by the FDA. What I suspect had much to do with the committee's final decision: A Merck's study, which simulated pharmacies selling Mevacor, failed to show consumers could properly decide on their own whether to take the statin. (Although the...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports